VHL and nonpapillary renal cell carcinoma: Additionally, investigating the clinical relevance of VHL-mediated m6A regulation in patient samples and evaluating the therapeutic potential of targeting m6A writers, readers, or erasers in ccRCC could be avenues for future studies.